BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16562370)

  • 41. Pancreatic cancer: new strategies available, but long battle ahead.
    Parvez T; Dawood T
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):303-4. PubMed ID: 12814523
    [No Abstract]   [Full Text] [Related]  

  • 42. Pancreatic cancer: between bench and bedside.
    Melisi D; Budillon A
    Curr Drug Targets; 2012 Jun; 13(6):729-30. PubMed ID: 22458518
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical investigations of innovative technologies of pancreatic cancer treatment].
    Khachatrian GR; Gostishchev RV
    Khirurgiia (Mosk); 2014; (11):73-80. PubMed ID: 25786281
    [No Abstract]   [Full Text] [Related]  

  • 44. Recent advances in diagnosis and treatment of pancreatic cancer.
    Nakao A
    Hepatogastroenterology; 2001; 48(40):914-5. PubMed ID: 11490839
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent progress in pancreatic cancer.
    Wolfgang CL; Herman JM; Laheru DA; Klein AP; Erdek MA; Fishman EK; Hruban RH
    CA Cancer J Clin; 2013 Sep; 63(5):318-48. PubMed ID: 23856911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreatic Cancer.
    Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):xiii-xiv. PubMed ID: 26226911
    [No Abstract]   [Full Text] [Related]  

  • 47. Cancer genetics: strategies for preventive oncology.
    Lynch HT; Lynch JF
    N Y State J Med; 1986 Apr; 86(4):172-3. PubMed ID: 3459068
    [No Abstract]   [Full Text] [Related]  

  • 48. Introduction.
    Harari PM
    Semin Radiat Oncol; 2006 Jan; 16(1):1. PubMed ID: 16378900
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in Pancreatic Cancer 2021: Introduction.
    Bentrem DJ; Rocha FG
    J Surg Oncol; 2021 May; 123(6):1369. PubMed ID: 33831246
    [No Abstract]   [Full Text] [Related]  

  • 50. Updates on the Management of Pancreatic Cancer.
    Tsai S; Evans DB
    Surg Oncol Clin N Am; 2021 Oct; 30(4):xvii-xviii. PubMed ID: 34511198
    [No Abstract]   [Full Text] [Related]  

  • 51. Palliation in pancreatic cancer: the controversies continue.
    Kaminski DL
    Curr Surg; 2005; 62(1):19-25. PubMed ID: 15708136
    [No Abstract]   [Full Text] [Related]  

  • 52. Controversies in upper GI oncology: maintenance treatment in pancreatic cancer.
    Dekervel J; Laheru D; O'Reilly EM
    ESMO Open; 2024 Feb; 9(2):102244. PubMed ID: 38350337
    [No Abstract]   [Full Text] [Related]  

  • 53. Pancreatic cancer: current standards, research updates and future directions.
    Hsueh CT
    J Gastrointest Oncol; 2011 Sep; 2(3):123-5. PubMed ID: 22811841
    [No Abstract]   [Full Text] [Related]  

  • 54. Anaesthetic perioperative management of patients with pancreatic cancer.
    De Pietri L; Montalti R; Begliomini B
    World J Gastroenterol; 2014 Mar; 20(9):2304-20. PubMed ID: 24605028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer.
    Dillhoff M; Yates R; Wall K; Muscarella P; Melvin WS; Ellison EC; Bloomston M
    J Gastrointest Surg; 2009 May; 13(5):825-30. PubMed ID: 19277793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Updates and controversies in the treatment of pancreatic cancer.
    Kosuri K; Muscarella P; Bekaii-Saab TS
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):47-54. PubMed ID: 16562370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force.
    Jafari M; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):751-60, xi. PubMed ID: 15350946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.